Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Multiple Myeloma
|
865 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.710 | 1.000 | 2 | 2013 | 2017 | ||||
Primary amyloidosis
|
11 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 1.000 | 2 | 2017 | 2017 | ||||
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
8 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 0 | |||||||
MULTIPLE MYELOMA, t(11;14) TYPE, SUSCEPTIBILITY TO
|
1 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 0 | |||||||
VON HIPPEL-LINDAU SYNDROME, MODIFIER OF
|
1 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 0 | |||||||
cervical cancer
|
268 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.040 | 1.000 | 4 | 2009 | 2018 | ||||
Cervix carcinoma
|
283 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.040 | 1.000 | 4 | 2009 | 2018 | ||||
Malignant tumor of cervix
|
245 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.040 | 1.000 | 4 | 2009 | 2018 | ||||
Benign Neoplasm
|
7 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Breast Carcinoma
|
2793 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Carcinogenesis
|
355 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Carcinoma of lung
|
1204 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Colon Carcinoma
|
275 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Congenital chromosomal disease
|
47 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Early-Stage Breast Carcinoma
|
7 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Head and Neck Carcinoma
|
118 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Lip and Oral Cavity Carcinoma
|
172 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Liver carcinoma
|
942 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant neoplasm of breast
|
3417 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Malignant neoplasm of lung
|
1142 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Malignant neoplasm of mouth
|
184 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Malignant neoplasm of thyroid
|
103 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Malignant Neoplasms
|
1641 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1 | 2018 | 2018 | |||||
Malignant tumor of colon
|
688 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2014 | 2014 |